Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 95

1.

Building successful relationships in the PLCO Cancer Screening Trial.

Marcus PM, Broski KG, Buys SS, Childs J, Church TR, Gohagan JK, Gren LH, Higgins D, Jaggi R, Jenkins V, Johnson CC, Lappe K, O'Brien B, Ogden SL, Prorok PC, Reding D, Shambaugh V, Yokochi LA, Yurgalevitch S.

Rev Recent Clin Trials. 2015 Jul 31. [Epub ahead of print]

PMID:
26238208
2.

Changes in and Impact of the Death Review Process in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.

Miller AB, Feld R, Fontana R, Gohagan JK, Jatoi I, Jr WL, Miller A, Prorok PC, Rajput A, Sherman M, Welch G, Wright P, Yurgalevitch S, Albertsen P.

Rev Recent Clin Trials. 2015 Jul 30. [Epub ahead of print]

PMID:
26238119
3.

Comprehensive Quality Management (CQM) in the PLCO Trial.

Gohagana JK, O'Brien B, Hasson MA, Umbel KD, Bridgeman B, Kramer BS, Reding D, Gren L, Wright P, Riley T, Prorok PC.

Rev Recent Clin Trials. 2015 Jul 30. [Epub ahead of print]

PMID:
26238118
4.

Data Processing and Analytic Support in the PLCO Cancer Screening Trial.

Mabie J, Riley T, Marcus PM, Black A, Rozjabek H, Yu K, Young M, Austin J, Rathmell J, Williams C, Prorok PC.

Rev Recent Clin Trials. 2015 Jul 30. [Epub ahead of print]

PMID:
26238116
5.

The PLCO Cancer Screening Trial: Background, Goals, Organization, Operations, Results.

Gohagan JK, Prorok PC, Greenwald P, Kramer BS.

Rev Recent Clin Trials. 2015 Jul 30. [Epub ahead of print]

PMID:
26238115
6.

Quantification of length-bias in screening trials with covariate-dependent test sensitivity.

Heltshe SL, Kafadar K, Prorok PC.

Biom J. 2015 May 15. doi: 10.1002/bimj.201400152. [Epub ahead of print]

PMID:
25980962
7.

Screening for Cancer: Lessons Learned from the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.

Grubb RL, Pinsky P, Prorok PC, Andriole GL.

Eur Urol. 2015 May 7. pii: S0302-2838(15)00328-0. doi: 10.1016/j.eururo.2015.04.026. [Epub ahead of print]

PMID:
25959167
8.

Occurrence of Distal Colorectal Neoplasia Among Whites and Blacks Following Negative Flexible Sigmoidoscopy: An Analysis of PLCO Trial.

Laiyemo AO, Doubeni C, Pinsky PF, Doria-Rose VP, Bresalier R, Hickey T, Riley T, Church TR, Weissfeld J, Schoen RE, Marcus PM, Prorok PC.

J Gen Intern Med. 2015 Apr 3. [Epub ahead of print]

PMID:
25835747
9.

Conceptualizing overdiagnosis in cancer screening.

Marcus PM, Prorok PC, Miller AB, DeVoto EJ, Kramer BS.

J Natl Cancer Inst. 2015 Feb 6;107(4). pii: djv014. doi: 10.1093/jnci/djv014. Print 2015 Apr.

PMID:
25663695
10.

Lead time and overdiagnosis.

Baker SG, Prorok PC, Kramer BS.

J Natl Cancer Inst. 2014 Oct 31;106(12). pii: dju346. doi: 10.1093/jnci/dju346. Print 2014 Dec. No abstract available. Erratum in: J Natl Cancer Inst. J Natl Cancer Inst. 2015 Mar;107(3):doi/10.1093/jnci/djv019.

PMID:
25362702
11.

Considerations in the design of randomized trials to screen for type 2 diabetes.

Echouffo-Tcheugui JB, Prorok PC.

Clin Trials. 2014 Jan 23;11(3):284-291. [Epub ahead of print]

PMID:
24459176
12.

The prostate, lung, colorectal, and ovarian cancer screening trial and its associated research resource.

Zhu CS, Pinsky PF, Kramer BS, Prorok PC, Purdue MP, Berg CD, Gohagan JK.

J Natl Cancer Inst. 2013 Nov 20;105(22):1684-93. doi: 10.1093/jnci/djt281. Epub 2013 Oct 10. Review.

13.

Diagnostic evaluation following a positive lung screening chest radiograph in the Prostate, Lung, Colorectal, Ovarian (PLCO) Cancer Screening Trial.

Hocking WG, Tammemagi MC, Commins J, Oken MM, Kvale PA, Hu P, Ragard LR, Riley TL, Pinsky P, Beck TM, Prorok PC.

Lung Cancer. 2013 Nov;82(2):238-44. doi: 10.1016/j.lungcan.2013.07.017. Epub 2013 Aug 7.

14.

Assessing the risk of ovarian malignancy in asymptomatic women with abnormal CA 125 and transvaginal ultrasound scans in the prostate, lung, colorectal, and ovarian screening trial.

Partridge EE, Greenlee RT, Riley TL, Commins J, Ragard L, Xu JL, Buys SS, Prorok PC, Fouad MN.

Obstet Gynecol. 2013 Jan;121(1):25-31. doi: http://10.1097/AOG.0b013e3182755e14.

15.

Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy.

Schoen RE, Pinsky PF, Weissfeld JL, Yokochi LA, Church T, Laiyemo AO, Bresalier R, Andriole GL, Buys SS, Crawford ED, Fouad MN, Isaacs C, Johnson CC, Reding DJ, O'Brien B, Carrick DM, Wright P, Riley TL, Purdue MP, Izmirlian G, Kramer BS, Miller AB, Gohagan JK, Prorok PC, Berg CD; PLCO Project Team.

N Engl J Med. 2012 Jun 21;366(25):2345-57. doi: 10.1056/NEJMoa1114635. Epub 2012 May 21.

16.

Colorectal cancers not detected by screening flexible sigmoidoscopy in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.

Schoen RE, Pinsky PF, Weissfeld JL, Yokochi LA, Church T, Laiyemo AO, Bresalier R, Hickey T, Riley T, Prorok PC.

Gastrointest Endosc. 2012 Mar;75(3):612-20. doi: 10.1016/j.gie.2011.10.024.

PMID:
22341106
17.

Flexible sigmoidoscopy in the randomized prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial: added yield from a second screening examination.

Weissfeld JL, Schoen RE, Pinsky PF, Bresalier RS, Doria-Rose VP, Laiyemo AO, Church T, Yokochi LA, Yurgalevitch S, Rathmell J, Andriole GL, Buys S, Crawford ED, Fouad M, Isaacs C, Lamerato L, Reding D, Prorok PC, Berg CD; PLCO Project Team.

J Natl Cancer Inst. 2012 Feb 22;104(4):280-9. doi: 10.1093/jnci/djr549. Epub 2012 Jan 31.

18.

Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up.

Andriole GL, Crawford ED, Grubb RL 3rd, Buys SS, Chia D, Church TR, Fouad MN, Isaacs C, Kvale PA, Reding DJ, Weissfeld JL, Yokochi LA, O'Brien B, Ragard LR, Clapp JD, Rathmell JM, Riley TL, Hsing AW, Izmirlian G, Pinsky PF, Kramer BS, Miller AB, Gohagan JK, Prorok PC; PLCO Project Team.

J Natl Cancer Inst. 2012 Jan 18;104(2):125-32. doi: 10.1093/jnci/djr500. Epub 2012 Jan 6.

19.

Longitudinal evaluation of CA-125 velocity and prediction of ovarian cancer.

Xu JL, Commins J, Partridge E, Riley TL, Prorok PC, Johnson CC, Buys SS.

Gynecol Oncol. 2012 Apr;125(1):70-4. doi: 10.1016/j.ygyno.2011.12.440. Epub 2011 Dec 22.

20.

Factors associated with inadequate colorectal cancer screening with flexible sigmoidoscopy.

Laiyemo AO, Doubeni C, Pinsky PF, Doria-Rose VP, Sanderson AK 2nd, Bresalier R, Weissfeld J, Schoen RE, Marcus PM, Prorok PC, Berg CD.

Cancer Epidemiol. 2012 Aug;36(4):395-9. doi: 10.1016/j.canep.2011.10.013. Epub 2011 Nov 22.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk